Losartan, an angiotensin II (AT1) receptor antagonist, preserves cerebral blood flow in hypertensive patients with a history of stroke
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
In patients with severe hypertension, chronic heart failure or a history of stroke, the lower limit of autoregulation of cerebral blood flow (CBF) is shifted to higher levels of blood pressure (BP) than those observed in healthy subjects. The aim of pharmacotherapy for hypertensive patients with an impaired autoregulation of CBF should be to reduce BP while preserving an appropriate CBF. In the present study, 16 hypertensive patients who had had an episode of stroke more than 4 weeks previously were administered the angiotensin II (AT1) receptor antagonist losartan at daily doses of 25-100 mg for 4 weeks. Systolic and diastolic blood pressures were recorded for 24 h using an ambulatory BP monitoring system. CBF in both hemispheres of the cerebrum and cerebellum was quantified using single photon emission tomography with N-isopropyl-p-[123I]iodoamphetamine. At baseline, CBF was 29.7 +/- 6.7 ml/min/100 g in the cerebrum and 31.5 +/- 7.5 ml/min/100 g in the cerebellum. At the end of treatment, BP was lower, while CBF increased by 7.7% in the cerebrum, and remained at the baseline level in the cerebellum. Thus, CBF was preserved despite the reduction in BP. We consider the use of losartan is advantageous for hypertensive patients with a history of stroke in whom autoregulation of CBF is potentially impaired.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ARBs may be superior to ACEIs188, because of their selective binding with the angiotensin receptor type I, since activation of angiotensin type II receptor has protective effects, leading to vasodilation, neuronal differentiation, and axonal regeneration189.”
From Mechanisms and treatment of late-life depression (2019) · cites this paper as [188]
Citations
Cites
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407
Autoregulation of Brain Circulation in Severe Arterial Hypertension
Strandgaard, S., Olesen, J., Skinhøj, E., & Lassen, N. A. (1973) · BMJ · doi:10.1136/bmj.1.5852.507 · Cited by 866
Recent Progress in Angiotensin II Type 2 Receptor Research in the Cardiovascular System
Horiuchi, M., Akishita, M., & Dzau, V. J. (1999) · Hypertension · doi:10.1161/01.hyp.33.2.613 · Cited by 473
Nishimura, Y., Ito, T., & Saavedra, J. M. (2000) · Stroke · doi:10.1161/01.str.31.10.2478 · Cited by 262
Quantitative mapping of regional cerebral blood flow using iodine-123-IMP and SPECT.
Iida, H., Itoh, H., Nakazawa, M., Hatazawa, J., Nishimura, H., Onishi, Y., & Uemura, K. (1994) · PubMed · Cited by 251
Neuroanatomy and Cranial Computed Tomography
Hj, K., & Weinrich, W. (1986) · Medical Entomology and Zoology · Cited by 140
Rajagopalan, B., Raine, A. E. G., Cooper, R., & Ledingham, J. G. G. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90891-x · Cited by 127
The chymase-angiotensin system in humans
Husain, A. (1993) · Journal of Hypertension · doi:10.1097/00004872-199311000-00001 · Cited by 117
Chymase-Dependent Angiotensin II Formation in Human Vascular Tissue
Takai, S., Jin, D., Sakaguchi, M., & Miyazaki, M. (1999) · Circulation · doi:10.1161/01.cir.100.6.654 · Cited by 107
Iida, H., Akutsu, T., Endo, K., Fukuda, H., Inoue, T., Ito, H., Koga, S., Komatani, A., Kuwabara, Y., Momose, T., et al. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199609000-00003 · Cited by 106
Research works printed but not linked: 1
- Kuriyama Y, Nakamura M, Sawada T, Omae T . Normalization of cerebral blood flow autoregulation after administration of a converting enzyme inhibitor (enalapril) in old stroke patients with hypertension. High Blood Pressure 1992; 1: 239–244.
Cited by
Mechanisms and treatment of late-life depression
Alexopoulos, G. S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0514-6 · Cited by 592
Targeting Renin–Angiotensin System Against Alzheimer’s Disease
Gebre, A. K., Altaye, B. M., Atey, T. M., Tuem, K. B., & Berhe, D. F. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00440 · Cited by 116
The CHHIPS Trial Group (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000160224.94220.e7 · Cited by 84
Chi, N., Hu, H., Wang, C.-Y., Chan, L., Peng, C., Novak, V., & Hu, C. (2018) · Stroke · doi:10.1161/strokeaha.118.022481 · Cited by 53
Angiotensin-II receptor blockers: benefits beyond blood pressure reduction?
Volpe, M., Ruilope, L. M., McInnes, G. T., Waeber, B., & Weber, M. A. (2005) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001831 · Cited by 50
Metadata
- Authors
- Moriwaki, H., Uno, H., Nagakane, Y., Hayashida, K., Miyashita, K., & Naritomi, H.
- Affiliations
- National Cerebral and Cardiovascular Center (JP)
- Corresponding author
- Moriwaki, H
- Venue
- Journal of Human Hypertension
- Published
- 2004-05-06
- Volume
- 18
- Issue
- 10
- Pages
- 693-699
- ISSN
- 0950-9240 (ISSN-L)
- 1476-5527
- OpenAlex
- W2036695904
- Cited by
- 36
- References
- 19
- Citations by year
- 2023: 1 · 2021: 3 · 2020: 1 · 2019: 1 · 2018: 4 · 2017: 2 · 2015: 1 · 2014: 1 · 2013: 1 · 2012: 2
- FWCI
- 1.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Journal of Human Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Keywords
- losartan, angiotensin II AT1 receptor antagonists, cerebral blood flow, cerebral autoregulation, hypertension, stroke, blood pressure reduction, cerebellar blood flow, ambulatory blood pressure monitoring
- MeSH terms
- Aged, Blood Pressure, Brain, Cerebrovascular Circulation, Female, Humans, Hypertension, Male, Middle Aged, Tomography, Emission-Computed, Single-Photon, Treatment Outcome, Blood Pressure Monitoring, Ambulatory, Radiopharmaceuticals, Losartan, Iofetamine, Stroke, Angiotensin II Type 1 Receptor Blockers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Losartan, an angiotensin II (AT1) receptor antagonist, preserves cerebral blood flow in hypertensive patients with a history of stroke. https://app.cochat.ai/papers/10.1038/sj.jhh.1001735
- The paper
- Moriwaki, H., Uno, H., Nagakane, Y., Hayashida, K., Miyashita, K., & Naritomi, H. (2004). Losartan, an angiotensin II (AT1) receptor antagonist, preserves cerebral blood flow in hypertensive patients with a history of stroke. Journal of Human Hypertension. https://doi.org/10.1038/sj.jhh.1001735
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.